John A. Butera

1.3k citations

38 papers · 945 indexed · h-index 19

Molecular Biology
Organic Chemistry top 10%
Cellular and Molecular Neuroscience top 10%
Cardiology and Cardiovascular Medicine top 10%
Physiology

Co-authors: Thomas M. Argentieri N. Wesley Norton Jeffrey H. Sheldon Hassan Elokdah James K. Hennan Robert E. Swillo Schuyler Antane Bradford Hirth
Topics: Cardiac electrophysiology and arrhythmias (9 papers)Neuroscience and Neuropharmacology Research (8 papers)Urinary Bladder and Prostate Research (5 papers)
Cited by: Organic Chemistry Cellular and Molecular Neuroscience Urology
Journals: Circulation Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Canada

In The Last Decade

John A. Butera

38 papers receiving 909 citations

Peers

Countries citing papers authored by John A. Butera

Since Specialization

Citations

This map shows the geographic impact of John A. Butera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Butera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Butera more than expected).

Fields of papers citing papers by John A. Butera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Butera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Butera. The network helps show where John A. Butera may publish in the future.

Co-authorship network of co-authors of John A. Butera

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Butera. A scholar is included among the top collaborators of John A. Butera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Butera. John A. Butera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	De novo synthesis of teleocidin B analogs 2010 ·Tetrahedron ·Jun Pu,Kangwen Deng,John A. Butera,Michael Chlenov,A. Gilbert,(unknown),James F. Mattes,Lynn Resnick	5
2	Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),John A. Butera,Arlene Dietrich,(unknown),Afshin Ghavami,Warren D. Hirst	36
3	The Gap Junction Modifier, GAP-134 [(2S,4R)-1-(2-Aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic Acid], Improves Conduction and Reduces Atrial Fibrillation/Flutter in the Canine Sterile Pericarditis Model 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Eric I. Rossman,Kun Liu,(unknown),Robert E. Swillo,Julie A. Krueger,Stephen J. Gardell,John A. Butera,(unknown),Joel Kantrowitz,Hal S. Feldman,Jørgen S. Petersen,Ketil Haugan,James K. Hennan	48
4	Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists 2009 ·European Journal of Pharmacology ·Julia Heinrich,John A. Butera,(unknown),Angela Krämer,Dianne Kowal,(unknown),Karen L. Marquis,Mark H. Pausch,(unknown),Shaiu-Ching Sun,Eugene Tseng,Albert J. Uveges,Scott C. Mayer	83
5	Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents 2009 ·Bioorganic & Medicinal Chemistry Letters ·Eugene L. Piatnitski Chekler,John A. Butera,Li Di,Robert E. Swillo,(unknown),Eric I. Rossman,Christine Huselton,Bjarne Due Larsen,James K. Hennan	8
6	Discovery of (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic Acid Hydrochloride (GAP-134)¹³, an Orally Active Small Molecule Gap-Junction Modifier for the Treatment of Atrial Fibrillation 2009 ·Journal of Medicinal Chemistry ·John A. Butera,Bjarne Due Larsen,James K. Hennan,Edward H. Kerns,Li Di,Asaf Alimardanov,Robert E. Swillo,(unknown),Kun Liu,Qiang Wang,Eric I. Rossman,Rayomand J. Unwalla,Leonard A. McDonald,Christine Huselton,Jørgen S. Petersen	35
7	Prodrugs of Perzinfotel with Improved Oral Bioavailability 2009 ·Journal of Medicinal Chemistry ·(unknown),John A. Butera,Magid Abou‐Gharbia,Hong Chen,Boyd L. Harrison,(unknown),Ronald L. Magolda,Jean Y. Sze,Michael R. Brandt,Terri Cummons,(unknown),Menelas N. Pangalos,Bojana Zupan,Matthew Hoffmann,Michael J. May,(unknown),Jeffrey D. Kennedy,Wayne E. Childers	27
8	Novel progesterone receptor modulators with gene selective and context-dependent partial agonism 2008 ·Biochemical Pharmacology ·Thomas J. Berrodin,Scott A. Jelinsky,Nilsa Graciani,John A. Butera,Zhiming Zhang,Sunil Nagpal,Richard C. Winneker,Matthew R. Yudt	18
9	Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs 2006 ·Journal of Pharmacology and Experimental Therapeutics ·James K. Hennan,Robert E. Swillo,(unknown),James C. Keith,Robert G. Schaub,Robert P. Smith,Hal S. Feldman,Ketil Haugan,Joel Kantrowitz,(unknown),Aqel W. Abu‐Qare,John A. Butera,Bjarne Due Larsen,David L. Crandall	71
10	Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones 2005 ·Bioorganic & Medicinal Chemistry Letters ·John A. Butera,(unknown),(unknown),Jeffrey H. Sheldon,N. Wesley Norton,(unknown),Thomas M. Argentieri	13
11	Characterization of Novel Aryl-Ether, Biaryl, and Fluorene Aspartic Acid and Diaminopropionic Acid Analogs as Potent Inhibitors of the High-Affinity Glutamate Transporter EAAT2 2005 ·Molecular Pharmacology ·John Dunlop,H. Beal McIlvain,(unknown),Brian Jow,Qiang Lü,Dianne Kowal,Steven Lin,(unknown),(unknown),Kristi Fan,Robert E. Petroski,John P. Williams,Alan C. Foster,John A. Butera	45
12	ZP123 Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs 2005 ·James K. Hennan,Hal S. Feldman,Robert E. Swillo,(unknown),James C. Keith,Robert G. Schaub,Robert P. Smith,Ketil Haugan,Joel Kantrowitz,John A. Butera,David L. Crandall	4
13	Synthesis and biological activities of aryl-ether-, biaryl-, and fluorene-aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT-2 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),John Dunlop,(unknown),(unknown),Brian Jow,(unknown),Dianne Kowal,John P. Williams,John A. Butera	28
14	Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry 2003 ·Journal of Pharmaceutical and Biomedical Analysis ·Meiyi Zhang,Edward H. Kerns,Oliver J. McConnell,June Sonnenberg‐Reines,Margaret M. Zaleska,J. Steven Jacobsen,John A. Butera,Anthony F. Kreft	15
15	Convenient synthesis of functionalized terphenyls 2003 ·Tetrahedron Letters ·(unknown),John A. Butera,Craig E. Caufield	17
16	Design, Synthesis, and Biological Evaluation of Thio-Containing Compounds with Serum HDL-Cholesterol-Elevating Properties 2003 ·Journal of Medicinal Chemistry ·Hassan Elokdah,(unknown),Magid Abou‐Gharbia,John A. Butera,(unknown),(unknown),Mar‐Lee McKean,John Babiak,Steven J. Adelman,Elaine Quinet	39
17	Synthesis and potassium channel opening activity of substituted 10H-Benzofuro[3,2-b]indole- and 5,10-Dihydro-indeno[1,2-b]indole-1-carboxylic acids 2001 ·Bioorganic & Medicinal Chemistry Letters ·John A. Butera,Schuyler Antane,Bradford Hirth,(unknown),Jeffrey H. Sheldon,N. Wesley Norton,(unknown),Thomas M. Argentieri	62
18	KCO-616 2000 ·Drugs of the Future ·John A. Butera,Thomas M. Argentieri	5
19	Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives 1991 ·Journal of Medicinal Chemistry ·John A. Butera,Walter Spinelli,(unknown),(unknown),(unknown),(unknown),(unknown),Jehan F. Bagli	24
20	Computer assisted design and synthesis of novel aldose reductase inhibitors 1989 ·Journal of Medicinal Chemistry ·John A. Butera,Jehan F. Bagli,Wendel W. Doubleday,Leslie G. Humber,Adi M. Treasurywala,Deborah A. Loughney,Kazimir Sestanj,Jane Millen,Janet Sredy	11

About John A. Butera

John A. Butera is a scholar working on Urology, Cellular and Molecular Neuroscience and Biochemistry, having authored 38 papers that have together received 945 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Urinary Bladder and Prostate Research (5 papers). The work is most often cited by research in Organic Chemistry (312 citations), Cellular and Molecular Neuroscience (175 citations) and Urology (55 citations). John A. Butera has collaborated with scholars based in United States and Canada. Frequent co-authors include Thomas M. Argentieri, N. Wesley Norton, Jeffrey H. Sheldon, Hassan Elokdah, James K. Hennan, Robert E. Swillo, Schuyler Antane, Bradford Hirth, John Dunlop and Eugene L. Piatnitski Chekler. Their work appears in journals such as Circulation, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact